Insights

View our latest blog posts, webinars and news stories below

Making Medicare Sustainable: A Guide to Policy Options for Congress and the Administration

Today, Leavitt Partners released a Medicare policy guide that provides an accessible overview of several major policy concepts that have circulated in Medicare reform conversations in recent years. With debate mounting over the future of Medicare, it is imperative that policymakers first understand these core policy proposals–including site neutral payments, competitive bidding in Medicare Advantage, … Continue reading

The Block Stops Here!

Information blocking continues to hinder timely access to electronic health data for patients, providers, payers, and the federal government. While federal regulations prohibit interference with data exchange, in practice information blocking remains largely unchecked. Because of insufficient enforcement of these regulations, data continue to be delayed or withheld from patients, clinicians, payers, and networks–resulting in … Continue reading

Leavitt Partners Expands FDA Capabilities as Former FDA Regulatory Expert Elaine Lippmann Joins the Firm

Leavitt Partners, an HMA Company, is pleased to announce that Elaine Lippmann, J.D., has joined the firm as a principal, located in Washington, D.C. Lippmann joins recently hired former U.S. Food and Drug Administration (FDA) leader Julie Tierney on an expert team of health policy and government affairs consultants at Leavitt Partners. Collectively, our bipartisan … Continue reading

FDA Regulatory Strategy, Federal Policy Development and Advocacy, and Alliance Building

THE CURRENT ENVIRONMENT  Life science organizations and other stakeholders impacted by the U.S. Food and Drug Administration (FDA) face exciting opportunities and demanding challenges, operating at the nexus of cutting-edge science, patient needs, and evolving regulatory requirements while facing political and regulatory scrutiny.   Novel therapies, including those created through advancements in cell and gene therapies, … Continue reading

Former Senior FDA Leader Julie Tierney Joins Leavitt Partners

Leavitt Partners, an HMA Company, is pleased to announce that Julie Tierney has joined the company’s team of health policy experts as a principal, located in Washington, D.C. Tierney is a proven executive with more than 20 years of FDA legal, policy, and operational experience. She held a number of senior roles at FDA, including … Continue reading

Webinar Replay – Kill the Clipboard: What Does the CMS-Aligned Network Strategy Mean for the Future of Interoperability

This webinar was held on Friday, August 8, 2025. This webinar examined two recent developments with the potential to reshape healthcare data exchange: the release of the Kill the Clipboard policy roadmap and the White House and CMS announcement of what they envision as a CMS-aligned network. While the past decade has brought significant policy … Continue reading

Webinar Replay – Kill the Clipboard: What the Federal RFI Signals About the Future of Health Care Data Exchange

This webinar was held on June 23, 2025. In March 2025, Leavitt Partners, an HMA Company, in conjunction with a number of multi-sector stakeholders, released Kill the Clipboard! A Federal Policy and Industry Roadmap to Accelerate Innovation and Cut Administrative Waste. Just three months later, the U.S. Department of Health and Human Services released its Request for … Continue reading

Survey Highlights Delays in Readiness for CMS Interoperability & Prior Authorization Final Rule

A recent survey conducted by WEDI, a national association for health IT guidance and collaboration, underscores significant delays among both providers and health plans in preparing for The Centers for Medicare & Medicaid Services (CMS)’s Interoperability and Prior Authorization Final Rule (CMS-0057-F). The rule introduces new requirements-including Fast Healthcare Interoperability Resources (FHIR) implementation and prior authorization … Continue reading

Senior Senate Finance Committee Staffer Joins Leavitt Partners

Leavitt Partners, an HMA Company, is pleased to announce that Conor Sheehey has joined the company’s team of health policy experts as a director, located in Washington, D.C. Sheehey most recently served as senior health policy advisor to U.S. Senate Finance Committee Chair Mike Crapo (R-ID). In this role, he advised the Committee on a … Continue reading

Webinar Replay – Digital Health & Interoperability Policy: New Ideas to Drive Federal Government Efficiency

This webinar was held on April 24, 2025. Building on previous successes across multiple administrations, we have an opportunity to continue to advance patient data exchange by taking an innovative approach to federal health care technology policy. How can we more effectively advance Fast Healthcare Interoperability Resources Application Programming Interface (FHIR API)-based data exchange between … Continue reading

©2025 Leavitt Partners. All rights reserved.

leavittpartners.com

Privacy Policy